Analysts' Actions: LB MYGN SP EXPE

NEW YORK (TheStreet) -- CHANGE IN RATINGS

L Brands (LB) was downgraded to hold at TheStreet Ratings.

Myriad Genetics (MYGN) was downgraded from market perform to underperform at JMP Securities. Twelve-month price target is $15. BRCA pricing is lower than expected, JMP Securities said.

SP Plus (SP) was upgraded to buy at TheStreet Ratings.

[Read: 4 Stocks Ready for Breakouts]

Stock Comments / EPS Changes

Expedia's (EXPE) 12-month price target was raised at Cantor Fitzgerald. Shares are now seen reaching $75. Checks point to higher site visitation in recent months, Cantor Fitzgerald said. Buy rating.

[Read: What Supplemental Health Care Has Been Costing Us]

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

More from Stocks

Stock Market Just Took Another Beating -- Here's What You Need to Know

Stock Market Just Took Another Beating -- Here's What You Need to Know

Starbucks Stock Performance in 2018: -12%

Starbucks Stock Performance in 2018: -12%

Dow Logs Eighth Straight Drop as Stocks Slump

Dow Logs Eighth Straight Drop as Stocks Slump

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Burger King Issues Apology After Massive World Cup Promotional Fail

Burger King Issues Apology After Massive World Cup Promotional Fail